LPP rs9860547: Genetics of Allergic Sensitization
rs9860547 is a common non-coding single nucleotide polymorphism located in an intron of the LPP gene on chromosome 3. Large-scale genome-wide association studies consistently link this variant to allergic sensitization, particularly polysensitization across common environmental triggers such as pollen, house dust mites, and animal dander. Carrying the risk allele is associated with a modest increase in the likelihood of producing allergen-specific IgE antibodies.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| GG | Carriers of two G alleles possess the baseline, non-risk genotype for this locus. Studies report standard population-level susceptibility to multi-allergen sensitization without the modest genetic elevation linked to the risk allele. Environmental factors and other genetic loci still predominantly shape overall allergy risk. | Favorable |
| AG | Heterozygous individuals inherit one copy of the risk-associated A allele and one non-risk G allele. Large-scale genetic studies associate this genotype with a modest statistical increase in the probability of producing specific IgE against environmental triggers like pollen or dander. This minor increase in relative odds does not guarantee that clinical allergy symptoms will ever develop. | Informational |
| AA | Carriers of two copies of the A allele possess the homozygous risk genotype associated with multi-allergen sensitization. Population cohorts show that having two risk alleles confers a small, incremental increase in the odds of polysensitization compared to heterozygous or non-risk genotypes. However, clinical manifestation remains heavily dependent on personal environmental exposures and broader polygenic architecture. | Higher attention |
Genomic Location and Variant Characteristics
The genetic variant rs9860547 is an intronic single nucleotide polymorphism situated on chromosome 3 at cytogenetic position 3q28, mapping within the LIM domain containing preferred translocation partner in lipoma (LPP) gene. As detailed in resources like dbSNP and the GWAS Catalog, the variant features an allele change between adenine (A) and guanine (G). Because it resides within an intron rather than a protein-coding exon, rs9860547 does not alter the primary amino acid sequence of the resulting protein. Instead, variants in this genomic region are thought to serve as regulatory markers or expression quantitative trait loci (eQTLs) that modulate how neighboring genes are transcribed and expressed in immune or barrier tissues.
The Biological Role of the LPP Gene
The LPP gene encodes a member of the zyxin family of LIM domain-containing proteins. LPP localizes primarily to focal adhesions—specialized multiprotein structures at the cell periphery that anchor the internal cytoskeleton to the extracellular matrix. Through these connections, LPP facilitates fundamental physiological processes including cell-to-cell adhesion, cell motility, structural signaling, and nucleocytoplasmic shuttling. In the context of immunology and allergic conditions, proper cellular adhesion and structural integrity in mucosal barriers (such as the respiratory epithelium) are critical for preventing allergen penetration. Furthermore, functional genomic studies indicate that regulatory variants near LPP may influence the activation and threshold responses of circulating immune cells.
Research Associations and Evidence Strength
Evidence linking rs9860547 to allergic sensitization is robust and well-replicated across independent human cohorts. Landmark genome-wide association studies (GWAS) on self-reported allergies and objective IgE-mediated allergic sensitization—including studies cataloged in PubMed and recent cross-ancestry analyses published in the Journal of Allergy and Clinical Immunology—demonstrate genome-wide significant associations with multisensitization. Individuals harboring the risk allele exhibit higher rates of allergic sensitization to diverse triggers, including grass pollen, cat dander, and dust mites. However, the effect size is typical of complex polygenic traits: each copy of the risk allele confers an odds ratio near 1.1 to 1.2, reflecting a slight statistical predisposition rather than a direct or deterministic cause of allergic disease.
Population Frequency and Ancestral Distribution
The rs9860547 variant is common across human populations worldwide, though its allele distribution varies between ancestral groups. In populations of European descent, the minor allele frequency is estimated at approximately 0.22, whereas in East Asian populations, it occurs at roughly 0.15. Global reference datasets such as gnomAD and 1000 Genomes reflect that both homozygous and heterozygous genotypes are frequently observed across diverse cohorts. Because this variant is widely distributed and ancient, it represents natural human genetic variation rather than a rare pathogenic mutation.
Clinical Interpretation and Practical Limitations
A person's genotype at rs9860547 cannot diagnose an allergy, nor does it predict with certainty whether an individual will develop clinical symptoms such as allergic rhinitis or asthma. Allergic sensitization is a complex trait governed by hundreds of interacting genetic loci combined with environmental exposures, lifestyle factors, and microbiome interactions. Possessing a risk genotype simply means one's statistical likelihood of sensitization across tested populations is modestly elevated. Genotyping results should never replace formal clinical allergy evaluations—such as skin prick testing or allergen-specific serum IgE measurements—which diagnose active disease under medical supervision.
How common is this variant?
The minor allele frequency for rs9860547 is approximately 0.22 in populations of European ancestry and roughly 0.15 in East Asian populations, with both the risk and non-risk alleles commonly detected globally.
Frequently asked questions
What does the rs9860547 variant in LPP indicate?
The rs9860547 variant in the LPP gene is a common genetic marker statistically associated with allergic sensitization. Carrying the risk allele is linked to a slightly higher likelihood of testing positive for IgE antibodies against common environmental allergens such as pollen, house dust mites, and pet dander.
Does having the risk genotype mean I am definitely allergic to dust or cats?
No. Genetics is only one component of allergic conditions, and rs9860547 confers only a very modest change in relative odds. Many individuals with the risk genotype never develop allergies, while others without the risk allele do experience severe symptoms due to other genetic and environmental factors.
How does the LPP gene relate to the immune system?
LPP produces a protein involved in focal adhesions and cellular structural maintenance, which plays a role in how cells adhere to one another and navigate tissues. Researchers hypothesize that variations in or near LPP may alter mucosal barrier permeability or influence how regulatory and immune cells communicate during foreign antigen exposure.
Can I use my rs9860547 genotype to choose allergy medications?
No, rs9860547 is a marker of trait susceptibility rather than a pharmacogenomic predictor of drug response. Any decisions regarding antihistamines, nasal corticosteroids, or immunotherapy should be based on clinical symptoms and guided by a qualified healthcare professional.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9860547?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29